Abstract
Objectives
Prostate cancer has few known risk factors. As part of a population-based case–control study conducted in four health maintenance organizations, the authors examined the associations between fatal prostate cancer and several medical and behavioral characteristics.
Methods
Cases were 768 health plan members who died of prostate adenocarcinoma during the period 1997–2001. We randomly selected controls (929) from the health plan membership and matched them to cases on health plan, age, race, and pattern of health plan membership. We examined medical records to obtain information on potential risk factors during the 10 years before the date on which prostate cancer was first suspected; the same reference date was used for the matched controls.
Results
Anthropometric characteristics, as well as personal histories of benign prostatic hypertrophy, transurethral prostatectomy, cancer, diabetes, prostatitis, hypertension, and vasectomy were largely similar for cases and controls. Men who died from prostate cancer were more likely than controls to have been cigarette smokers according to the most recent smoking notation before the reference date (odds ratio 1.5, 95% confidence interval 1.1–2.0).
Conclusions
The observed increase in risk associated with recent cigarette smoking is consistent with the findings of several other studies. However, in contrast with some reports, we observed no connection between fatal prostate cancer and some prior health conditions or measures of body size.
Similar content being viewed by others
References
US Cancer Statistics Working Group (2007) United States Cancer Statistics: 1999–2004 incidence and mortality web-based report. Atlanta: US Department of Health and Human Services, Center for Disease Control and Prevention and National Cancer Institute. Available at www.cdc.gov/ASCS
Platz EA, Giovannucci E (2006) Prostate cancer. Oxford University Press, New York
Weinmann S, Richert-Boe KE, Van Den Eeden SK et al (2005) Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality: a case-control study. Epidemiology 16:367–376
Ries LA, Eisner MP, Kosary CL (2001) SEER cancer statistics review. 1973–1998. In: Ries LA, Eisner MP, Kosary CL (eds). Bethesda
Giovannucci E (2007) Does prostate-specific antigen screening influence the results of studies of tomatoes, lycopene, and prostate cancer risk? J Natl Cancer Inst 99:1060–1062
Freedland SJ, Platz EA (2007) Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev 29:88–97
Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC (2007) Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 121:1571–1578
Hiatt RA, Armstrong MA, Klatsky AL, Sidney S (1994) Alcohol consumption, smoking, and other risk factors and prostate cancer in a large health plan cohort in California (United States). Cancer Causes Control 5:66–72
Armenian HK, Lilienfeld AM, Diamond EL, Bross ID (1974) Relation between benign prostatic hyperplasia and cancer of the prostate. A prospective and retrospective study. Lancet 2:115–117
Chokkalingam AP, Nyren O, Johansson JE et al (2003) Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia: a population-based cohort study in Sweden. Cancer 98:1727–1734
Simons BD, Morrison AS, Young RH, Verhoek-Oftedahl W (1993) The relation of surgery for prostatic hypertrophy to carcinoma of the prostate. Am J Epidemiol 138:294–300
Guess HA (2001) Benign prostatic hyperplasia and prostate cancer. Epidemiol Rev 23:152–158
Greenwald P, Kirmss V, Polan AK, Dick VS (1974) Cancer of the prostate among men with benign prostatic hyperplasia. J Natl Cancer Inst 53:335–340
Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160–1167
Calton BA, Chang SC, Wright ME et al (2007) History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP diet and health study. Cancer Causes Control 18:493–503
Will JC, Vinicor F, Calle EE (1999) Is diabetes mellitus associated with prostate cancer incidence and survival? Epidemiology 10:313–318
Giovannicci E (2001) Medical history and etiology of prostate cancer. Epidemiologic Rev 23:159–162
Rodriguez C, Patel AV, Mondul AM, Jacobs EJ, Thun MJ, Calle EE (2005) Diabetes and risk of prostate cancer in a prospective cohort of US men. Am J Epidemiol 161:147–152
Weiderpass E, Ye W, Vainio H, Kaaks R, Adami HO (2002) Reduced risk of prostate cancer among patients with diabetes mellitus. Int J Cancer 102:258–261
Gong Z, Neuhouser ML, Goodman PJ et al (2006) Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 15:1977–1983
Zhu K, Lee IM, Sesso HD, Buring JE, Levine RS, Gaziano JM (2004) History of diabetes mellitus and risk of prostate cancer in physicians. Am J Epidemiol 159:978–982
Rosenberg DJ, Neugut AI, Ahsan H, Shea S (2002) Diabetes mellitus and the risk of prostate cancer. Cancer Invest 20:157–165
Coker AL, Sanderson M, Zheng W, Fadden MK (2004) Diabetes mellitus and prostate cancer risk among older men: population-based case-control study. Br J Cancer 90:2171–2175
Lightfoot N, Conlon M, Kreiger N, Sass-Kortsak A, Purdham J, Darlington G (2004) Medical history, sexual, and maturational factors and prostate cancer risk. Ann Epidemiol 14:655–662
Tavani A, Gallus S, Bosetti C et al (2002) Diabetes and the risk of prostate cancer. Eur J Cancer Prev 11:125–128
Lund Nilsen TI, Johnsen R, Vatten LJ (2000) Socio-economic and lifestyle factors associated with the risk of prostate cancer. Br J Cancer 82:1358–1363
Mishina T, Watanabe H, Araki H, Nakao M (1985) Epidemiological study of prostatic cancer by matched-pair analysis. Prostate 6:423–436
Rohrmann S, Paltoo DN, Platz EA, Hoffman SC, Comstock GW, Helzlsouer KJ (2005) Association of vasectomy and prostate cancer among men in a Maryland cohort. Cancer Causes Control 16:1189–1194
Cox B, Sneyd MJ, Paul C, Delahunt B, Skegg DC (2002) Vasectomy and risk of prostate cancer. JAMA 287:3110–3115
Dennis LK, Dawson DV, Resnick MI (2002) Vasectomy and the risk of prostate cancer: a meta-analysis examining vasectomy status, age at vasectomy, and time since vasectomy. Prostate Cancer Prostatic Dis 5:193–203
Bernal-Delgado E, Latour-Perez J, Pradas-Arnal F, Gomez-Lopez LI (1998) The association between vasectomy and prostate cancer: a systematic review of the literature. Fertil Steril 70:191–200
Honda GD, Bernstein L, Ross RK, Greenland S, Gerkins V, Henderson BE (1988) Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men. Br J Cancer 57:326–331
Mettlin C, Natarajan N, Huben R (1990) Vasectomy and prostate cancer risk. Am J Epidemiol 132:1056–1061
Giovannucci E, Tosteson TD, Speizer FE, Ascherio A, Vessey MP, Colditz GA (1993) A retrospective cohort study of vasectomy and prostate cancer in US men. JAMA 269:878–882
Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1993) A prospective cohort study of vasectomy and prostate cancer in US men. JAMA 269:873–877
Platz EA, Yeole BB, Cho E, Jussawalla DJ, Giovannucci E, Ascherio A (1997) Vasectomy and prostate cancer: a case-control study in India. Int J Epidemiol 26:933–938
Lesko SM, Louik C, Vezina R, Rosenberg L, Shapiro S (1999) Vasectomy and prostate cancer. J Urol 161:1848–1852
DerSimonian R, Clemens J, Spirtas R, Perlman J (1993) Vasectomy and prostate cancer risk: methodological review of the evidence. J Clin Epidemiol 46:163–172
Hickey K, Do KA, Green A (2001) Smoking and prostate cancer. Epidemiol Rev 23:115–125
Adami HO, Bergstrom R, Engholm G et al (1996) A prospective study of smoking and risk of prostate cancer. Int J Cancer 67:764–768
Hsing AW, McLaughlin JK, Hrubec Z, Blot WJ, Fraumeni JF Jr (1991) Tobacco use and prostate cancer: 26-year follow-up of US veterans. Am J Epidemiol 133:437–441
Hsing AW, McLaughlin JK, Schuman LM et al (1990) Diet, tobacco use, and fatal prostate cancer: results from the Lutheran brotherhood cohort study. Cancer Res 50:6836–6840
Tverdal A, Thelle D, Stensvold I, Leren P, Bjartveit K (1993) Mortality in relation to smoking history: 13 years’ follow-up of 68, 000 Norwegian men and women 35–49 years. J Clin Epidemiol 46:475–487
Coughlin SS, Neaton JD, Sengupta A (1996) Cigarette smoking as a predictor of death from prostate cancer in 348, 874 men screened for the multiple risk factor intervention trial. Am J Epidemiol 143:1002–1006
Doll R, Peto R, Wheatley K, Gray R, Sutherland I (1994) Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ 309:901–911
Carstensen JM, Pershagen G, Eklund G (1987) Mortality in relation to cigarette and pipe smoking: 16 years’ observation of 25, 000 Swedish men. J Epidemiol Community Health 41:166–172
Rohrmann S, Genkinger JM, Burke A et al (2007) Smoking and risk of fatal prostate cancer in a prospective US study. Urology 69:721–725
Rodriguez C, Tatham LM, Thun MJ, Calle EE, Heath CW Jr (1997) Smoking and fatal prostate cancer in a large cohort of adult men. Am J Epidemiol 145:466–475
Nomura AM (2001) Body size and prostate cancer. Epidemiol Rev 23:126–131
O’Malley RL, Taneja SS (2006) Obesity and prostate cancer. Can J Urol 13(Suppl 2):11–17
Rodriguez C, Patel AV, Calle EE, Jacobs EJ, Chao A, Thun MJ (2001) Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev 10:345–353
Andersson SO, Wolk A, Bergstrom R et al (1997) Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 89:385–389
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348:1625–1638
Wright ME, Chang SC, Schatzkin A et al (2007) Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 109:675–684
Rodriguez C, Freedland SJ, Deka A et al (2007) Body mass index, weight change, and risk of prostate cancer in the cancer prevention study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 16:63–69
Engeland A, Tretli S, jorge T (2003) Height, body mass index, and prostate cancer: a follow-up of 950,000 Norwegian men. British J Cancer 89:237–242
Pan SY, Johnson KC, Ugnat AM, Wen SW, Mao Y (2004) Association of obesity and cancer risk in Canada. Am J Epidemiol 159:259–268
Sequoia JS, Wright ME, McCarron P et al (2006) A prospective investigation of height and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 15:2174–2178
Acknowledgments
The authors extend gratitude to the following contributors to this work: Bradley Crane and Jeff Showell (KPNW) for data management and computer programming; Susan Salk (KPNC), Christine Neslund-Dudas (HFHS), and Julie Stern (KPSC), for coordination of medical record abstraction; and Lynn Bonney (KPNW) for assistance with data coding and analysis.
Funding: This research was supported by Centers for Disease Control and Prevention Purchase Order MLM000HCL84-2004-10249 and Task Order 0953-20.
Author information
Authors and Affiliations
Corresponding author
Additional information
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Rights and permissions
About this article
Cite this article
Weinmann, S., Shapiro, J.A., Rybicki, B.A. et al. Medical history, body size, and cigarette smoking in relation to fatal prostate cancer. Cancer Causes Control 21, 117–125 (2010). https://doi.org/10.1007/s10552-009-9441-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-009-9441-9